Breast Cancer Clinical Trials near Phoenix, AZ
68 studies for Breast Cancer are recruiting at 93 sites within 50 miles of Phoenix, Arizona, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all Breast Cancer trials in the US or all trials near Phoenix.
Recruiting now
Breast Cancer studies enrolling near Phoenix
- The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
NCT06377852
- Phase 3
- Ages 60 years and older
- Sex: All
Nearest sites: Ironwood Cancer & Research Centers (Phoenix, AZ); Ironwood Cancer & Research Centers (Glendale, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 8 sites within 50 mi
- A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
NCT07062965
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest sites: Ironwood Cancer & Research Centers (Phoenix, AZ); Ironwood Cancer & Research Centers (Glendale, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 8 sites within 50 mi
- A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
NCT06492616
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest sites: Banner University Medical Center - Phoenix Campus (Banner Good Samaritan Medical Center) (Phoenix, AZ); Mayo Clinic (Scottsdale, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 50 mi
- Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
NCT05812807
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest sites: Cancer Center at Saint Joseph's (Phoenix, AZ); Mayo Clinic Hospital in Arizona (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
NCT04981119
- Observational
- Ages 18 years and older
- Sex: All
Nearest sites: Mayo Clinic Hospital (Phoenix, AZ); Banner Health (Gilbert, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
NCT05879926
- Phase 3
- Ages 18 to 60 years
- Sex: Female
Nearest sites: Cancer Center at Saint Joseph's (Phoenix, AZ); Mayo Clinic Hospital in Arizona (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
NCT06790693
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest sites: The Dignity Health Cancer Institute (Phoenix, AZ); City of Hope - Phoenix (Goodyear, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest sites: Mayo Clinic Cancer Center ( Site 0034) (Phoenix, AZ); Banner MD Anderson Cancer Center ( Site 0066) (Gilbert, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
NCT03053193
- Observational
- Ages 18 years and older
- Sex: All
Nearest site: Arizona Oncology Associates, PC (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
NCT03723928
- Interventional
- Ages 18 years and older
- Sex: All
Nearest site: Cancer Center at Saint Joseph's (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Breast Cancer, Reasoning, and Activity Intervention
NCT04816006
- Interventional
- Ages 50 years and older
- Sex: Female
Nearest site: Mayo Clinic in Arizona (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
NCT04852887
- Phase 3
- Ages 50 to 70 years
- Sex: All
Nearest site: Cancer Center at Saint Joseph's (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069
- Observational
- Ages 40 to 75 years
- Sex: All
- Accepts healthy volunteers
Nearest site: Cancer Center at Saint Joseph's (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
NCT05377996
- Phase 1/2
- Ages 18 years and older
- Sex: All
Nearest site: Mayo Clinic Comprehensive Cancer Center (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
NCT05467891
- Phase 2
- Ages 18 years and older
- Sex: All
Nearest site: University of Arizona (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
NCT05579366
- Phase 1/2
- Ages 18 years and older
- Sex: All
Nearest site: USOR HonorHealth (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
NCT05929768
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest site: Cancer Center at Saint Joseph's (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
NCT06072612
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest site: Mayo Clinic-Comprehensive Cancer Center-Breast Clinic (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
NCT06349642
- Observational
- Ages 18 years and older
- Sex: All
Nearest site: Mayo Clinic in Arizona (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
NCT06369285
- Phase 2
- Ages 18 years and older
- Sex: All
Nearest site: Mayo Clinic Hospital (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
NCT06395519
- Phase 1/2
- Ages 18 years and older
- Sex: All
Nearest site: Mayo Clinic (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
NCT06418204
- Observational
- Ages 18 years and older
- Sex: All
Nearest site: Cancer Center at Saint Joseph's (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
NCT06435429
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest site: Mayo Clinic Scottsdale - PPDS (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
NCT06500481
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest site: Mayo Clinic Hospital in Arizona (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- E-Mindfulness Approaches for Living After Breast Cancer
NCT06748222
- Phase 3
- Ages 18 to 50 years
- Sex: All
Nearest site: Mayo Clinic Hospital in Arizona (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
NCT06876714
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest site: Mayo Clinic Hospital in Arizona (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- The RolE of Prolonged Nightly faSTing to Improve Sleep and cOgnition in bREast Cancer Survivors
NCT06938555
- Interventional
- Ages 18 years and older
- Sex: All
Nearest site: Arizona State University (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
NCT07007559
- Phase 2
- Ages 18 years and older
- Sex: All
Nearest site: Mayo Clinic Building-Phoenix (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening
NCT07219277
- Observational
- Ages 30 to 75 years
- Sex: Female
- Accepts healthy volunteers
Nearest site: Vincere Cancer Center (Phoenix, AZ)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
NCT05633654
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest site: Palo Verde Hematology Oncology (Glendale, AZ)
- Distance to nearest recruiting site
- ~9 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
NCT07361562
- Phase 1
- Ages 18 years and older
- Sex: All
Nearest sites: HonorHealth Research Institute (Scottsdale, AZ); Mayo Scottsdale (Scottsdale, AZ)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
NCT01766297
- Phase 2
- Ages 50 years and older
- Sex: Female
Nearest site: Mayo Clinic (Scottsdale, AZ)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- The PREDICT Registry:
NCT03448926
- Observational
- Ages 30 to 85 years
- Sex: Female
Nearest site: Arizona Center for Cancer Care (Scottsdale, AZ)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
NCT03452774
- Observational
- Ages Any age
- Sex: All
Nearest site: Massive Bio SYNERGY-AI site (Scottsdale, AZ)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
NCT04282044
- Phase 1
- Ages 18 years and older
- Sex: All
Nearest site: HonorHealth Research Institute (Scottsdale, AZ)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
NCT04373564
- Phase 4
- Ages 18 to 64 years
- Sex: All
Nearest site: Scottsdale Medical Imaging, LLC (Scottsdale, AZ)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Cancer Genetic Testing in Ethnic Populations
NCT04475640
- Interventional
- Ages 18 years and older
- Sex: All
Nearest site: Mayo Clinic in Arizona (Scottsdale, AZ)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
NCT04787042
- Phase 1/2
- Ages 18 years and older
- Sex: All
Nearest site: HonorHealth Research Institute (Scottsdale, AZ)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
NCT05696626
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest site: Mayo Clinic - Scottsdale (Scottsdale, AZ)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
NCT05824975
- Phase 1/2
- Ages 18 years and older
- Sex: All
Nearest site: Mayo Clinic in Arizona (Scottsdale, AZ)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
NCT05856773
- Phase 3
- Ages 19 years and older
- Sex: Female
Nearest site: Mayo Clinic (Scottsdale, AZ)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
NCT06400472
- Phase 1
- Ages 18 years and older
- Sex: All
Nearest site: HonorHealth (Scottsdale, AZ)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Turkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery
NCT06450873
- Phase 2
- Ages 18 years and older
- Sex: Female
Nearest site: Mayo Clinic in Arizona (Scottsdale, AZ)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer
NCT06525766
- Phase 2
- Ages 18 years and older
- Sex: All
Nearest site: Mayo Clinic in Arizona (Scottsdale, AZ)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
NCT06635980
- Phase 2
- Ages 18 years and older
- Sex: Female
Nearest site: Mayo Clinic in Arizona (Scottsdale, AZ)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
NCT06778863
- Phase 1
- Ages 18 years and older
- Sex: All
Nearest site: HonorHealth Research Institute (Scottsdale, AZ)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer
NCT06855524
- Phase 2
- Ages 18 years and older
- Sex: All
Nearest site: Mayo Clinic in Arizona (Scottsdale, AZ)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
NCT07383506
- Phase 1
- Ages 18 years and older
- Sex: All
Nearest site: HonorHealth Research Institute (Scottsdale, AZ)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
NCT07454642
- Phase 1
- Ages 18 years and older
- Sex: All
Nearest site: Honor Health Research Institute (Scottsdale, AZ)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
NCT07705334
- Phase 1
- Ages 18 years and older
- Sex: All
Nearest site: HonorHealth Research Institute (Scottsdale, AZ)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining a Breast Cancer clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.